ISRCTN28353453CompletedNot Applicable
A controlled trial of terlipressin plus banding ligation versus terlipressin alone in the management of acute esophageal variceal bleeding
Republic of China National Science Council (Taiwan)0 sites120 target enrollmentStarted: March 30, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Cirrhotic patients
- •2. Acute oesophageal variceal bleeding proven by emergency endoscopy within 12 hours
Exclusion Criteria
- •1. Association with advanced hepatocellular carcinoma (HCC)
- •2. Association with other severe systemic illness
- •3. Association with gastric variceal bleeding
- •4. Previous shunt operation, endoscopic variceal ligation (EVL), beta-blocker or isosorbide mononitrate (ISMN) within one month
- •5. Serum bilirubin >10 mg/dl, creatinine >3 mg/dl
- •6. Presence of encephalopathy >grade 2
- •6. History of coronary artery disease
- •7. Uncooperative
Investigators
Similar Trials
Completed
Not Applicable
To compare low cost treatment regimen with standard treatment in patients with hepatorenal syndromeCTRI/2011/07/001860il80
Completed
Phase 3
Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1Hepatorenal SyndromeNCT00089570Mallinckrodt112
Completed
Not Applicable
Effects of Terlipressin on Renal Perfusion in Patients With Septic ShockSeptic ShockNCT04948372Southeast University, China22
Completed
Phase 3
The impact of continuous terlipressin infusion on complications of end-stage liver diseaseSarcopaeniaInflammationMalnutritionAscitesInfectionImmune functionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersDiet and Nutrition - Other diet and nutrition disordersInflammatory and Immune System - Other inflammatory or immune system disordersCirrhosisHepatic encephalopathyACTRN12619000891123Austin Health30
Not yet recruiting
Phase 2
Comparison of Terlipressin and low dose Terlipressin and noradrenalin in HRS-AKI patients of ACLFCTRI/2023/10/058546on sponsered
